Magellan Health, Inc. (MGLN): Price and Financial Metrics
Magellan Health, Inc. (MGLN)
Today's Latest Price: $94.72 USD
Updated Jan 25 3:46pm
Add MGLN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 8 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
MGLN Stock Summary
- Of note is the ratio of Magellan Health Inc's sales and general administrative expense to its total operating expenses; merely 0.48% of US stocks have a lower such ratio.
- MGLN's price/sales ratio is 0.41; that's higher than the P/S ratio of just 9.5% of US stocks.
- Over the past twelve months, MGLN has reported earnings growth of 154.89%, putting it ahead of 91.51% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Magellan Health Inc, a group of peers worth examining would be CHCT, TRNO, RTLR, UBA, and AJRD.
- Visit MGLN's SEC page to see the company's official filings. To visit the company's web site, go to www.magellanhealth.com.
MGLN Stock Price Chart Interactive Chart >
MGLN Price/Volume Stats
| Current price | $94.72 | 52-week high | $95.43 |
| Prev. close | $94.55 | 52-week low | $30.60 |
| Day low | $94.40 | Volume | 241,818 |
| Day high | $94.78 | Avg. volume | 855,000 |
| 50-day MA | $84.91 | Dividend yield | N/A |
| 200-day MA | $74.93 | Market Cap | 2.43B |
Magellan Health, Inc. (MGLN) Company Bio
Magellan Health provides services to health plans, managed care organizations (MCOs), employers, labor unions, military and governmental agencies, third party administrators, consultants and brokers. Its business is divided into five segments, which include managed healthcare, specialty solutions and pharmacy management. The company was founded in 1969 and is based in Scottsdale, Arizona.
MGLN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $94.72 | $52.77 | -44% |
We started the process of determining a valid price forecast for Magellan Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Magellan Health Inc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MGLN, they are:
- Magellan Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 18.21% of tickers in our DCF set.
- Magellan Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
- Relative to other stocks in its sector (Healthcare), Magellan Health Inc has a reliance on debt greater than 65.29% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -45% |
| 1% | -45% |
| 2% | -44% |
| 3% | -44% |
| 4% | -43% |
| 5% | -43% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MGLN, try CRL, ITGR, MMSI, PKI, and IART.
Loading social stream, please wait...